Will Walgreens Investors Be Rewarded For Patience?

Although Walgreens Boots Alliance (NASDAQ: WBA) reported stronger than expected Q2 results on April 2, the stock is down almost 30% in 2020 as investors are concerned that revenues will decline meaningfully in the second half of fiscal 2020 due to the COVID-19 pandemic. While it's difficult to forecast how much and how long the virus will hurt the company, U.S. sales should eventually stabilize and rebound.

More importantly, Walgreens' attractive dividend yield and its financial strength mitigate the risk of COVID-19 significantly disrupting its operations in the near-term. Here's why Walgreens investors should hang onto this healthcare stock.

Image Source: Getty Images

Source Fool.com